ID   LMBL1_HUMAN             Reviewed;         840 AA.
AC   Q9Y468; B4DRC9; E1P5W7; Q5H8Y8; Q5H8Y9; Q8IUV7; Q9H1E6; Q9H1G5; Q9UG06;
AC   Q9UJB9; Q9Y4C9;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 4.
DT   07-APR-2021, entry version 206.
DE   RecName: Full=Lethal(3)malignant brain tumor-like protein 1;
DE            Short=H-l(3)mbt;
DE            Short=H-l(3)mbt protein;
DE            Short=L(3)mbt-like;
DE   AltName: Full=L(3)mbt protein homolog;
DE   AltName: Full=L3MBTL1;
GN   Name=L3MBTL1; Synonyms=KIAA0681, L3MBT, L3MBTL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10445843; DOI=10.1038/sj.onc.1202732;
RA   Koga H., Matsui S., Hirota T., Takebayashi S., Okumura K., Saya H.;
RT   "A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt)
RT   protein associates with condensed mitotic chromosomes.";
RL   Oncogene 18:3799-3809(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT THR-117.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 283-840 (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [7]
RP   INTERACTION WITH ETV6.
RX   PubMed=12588862; DOI=10.1074/jbc.m300592200;
RA   Boccuni P., MacGrogan D., Scandura J.M., Nimer S.D.;
RT   "The human L(3)MBT Polycomb group protein is a transcriptional repressor
RT   and interacts physically and functionally with TEL (ETV6).";
RL   J. Biol. Chem. 278:15412-15420(2003).
RN   [8]
RP   IMPRINTING.
RX   PubMed=15123827; DOI=10.1073/pnas.0308195101;
RA   Li J., Bench A.J., Vassiliou G.S., Fourouclas N., Ferguson-Smith A.C.,
RA   Green A.R.;
RT   "Imprinting of the human L3MBTL gene, a polycomb family member located in a
RT   region of chromosome 20 deleted in human myeloid malignancies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:7341-7346(2004).
RN   [9]
RP   FUNCTION, INTERACTION WITH CBX3 AND HISTONES, AND MUTAGENESIS OF ASP-316;
RP   PHE-340; ASP-423; PHE-447; ASP-527 AND PHE-551.
RX   PubMed=17540172; DOI=10.1016/j.cell.2007.03.048;
RA   Trojer P., Li G., Sims R.J. III, Vaquero A., Kalakonda N., Boccuni P.,
RA   Lee D., Erdjument-Bromage H., Tempst P., Nimer S.D., Wang Y.H.,
RA   Reinberg D.;
RT   "L3MBTL1, a histone-methylation-dependent chromatin lock.";
RL   Cell 129:915-928(2007).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH KMT5A.
RX   PubMed=18408754; DOI=10.1038/onc.2008.67;
RA   Kalakonda N., Fischle W., Boccuni P., Gurvich N., Hoya-Arias R., Zhao X.,
RA   Miyata Y., Macgrogan D., Zhang J., Sims J.K., Rice J.C., Nimer S.D.;
RT   "Histone H4 lysine 20 monomethylation promotes transcriptional repression
RT   by L3MBTL1.";
RL   Oncogene 27:4293-4304(2008).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH RB1.
RX   PubMed=20870719; DOI=10.1074/jbc.m110.137612;
RA   Saddic L.A., West L.E., Aslanian A., Yates J.R. III, Rubin S.M., Gozani O.,
RA   Sage J.;
RT   "Methylation of the retinoblastoma tumor suppressor by SMYD2.";
RL   J. Biol. Chem. 285:37733-37740(2010).
RN   [12]
RP   UBIQUITINATION, AND INTERACTION WITH VCP.
RX   PubMed=22120668; DOI=10.1038/nsmb.2188;
RA   Acs K., Luijsterburg M.S., Ackermann L., Salomons F.A., Hoppe T.,
RA   Dantuma N.P.;
RT   "The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from
RT   DNA double-strand breaks.";
RL   Nat. Struct. Mol. Biol. 18:1345-1350(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 265-595.
RX   PubMed=12842041; DOI=10.1016/s0969-2126(03)00127-8;
RA   Wang W.K., Tereshko V., Boccuni P., MacGrogan D., Nimer S.D., Patel D.J.;
RT   "Malignant brain tumor repeats: a three-leaved propeller architecture with
RT   ligand/peptide binding pockets.";
RL   Structure 11:775-789(2003).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 274-587 IN COMPLEX WITH
RP   MONOMETHYLATED AND DIMETHYLATED PEPTIDES, DOMAIN MBT REPEAT, AND
RP   MUTAGENESIS OF ASP-423 AND ASN-426.
RX   PubMed=18042461; DOI=10.1016/j.molcel.2007.10.023;
RA   Li H., Fischle W., Wang W., Duncan E.M., Liang L., Murakami-Ishibe S.,
RA   Allis C.D., Patel D.J.;
RT   "Structural basis for lower lysine methylation state-specific readout by
RT   MBT repeats of L3MBTL1 and an engineered PHD finger.";
RL   Mol. Cell 28:677-691(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 268-598 IN COMPLEX WITH
RP   DIMETHYLATED HISTONE H4, AND MUTAGENESIS OF ASP-423 AND CYS-431.
RX   PubMed=18026117; DOI=10.1038/nsmb1340;
RA   Min J., Allali-Hassani A., Nady N., Qi C., Ouyang H., Liu Y., MacKenzie F.,
RA   Vedadi M., Arrowsmith C.H.;
RT   "L3MBTL1 recognition of mono- and dimethylated histones.";
RL   Nat. Struct. Mol. Biol. 14:1229-1230(2007).
RN   [17]
RP   ERRATUM OF PUBMED:18026117.
RA   Min J., Allali-Hassani A., Nady N., Qi C., Ouyang H., Liu Y., MacKenzie F.,
RA   Vedadi M., Arrowsmith C.H.;
RL   Nat. Struct. Mol. Biol. 15:114-114(2008).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 259-598 IN COMPLEX WITH
RP   MONOMETHYLATED PEPTIDE, FUNCTION, INTERACTION WITH TP53, AND MUTAGENESIS OF
RP   ASP-423; ASN-426; PHE-447; TRP-450 AND TYR-454.
RX   PubMed=20870725; DOI=10.1074/jbc.m110.139527;
RA   West L.E., Roy S., Lachmi-Weiner K., Hayashi R., Shi X., Appella E.,
RA   Kutateladze T.G., Gozani O.;
RT   "The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine
RT   382 to target gene repression.";
RL   J. Biol. Chem. 285:37725-37732(2010).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 268-590.
RG   Structural genomics consortium (SGC);
RT   "Small molecule ligands of methyl-lysine binding proteins.";
RL   Submitted (NOV-2010) to the PDB data bank.
CC   -!- FUNCTION: Polycomb group (PcG) protein that specifically recognizes and
CC       binds mono- and dimethyllysine residues on target proteins, therey
CC       acting as a 'reader' of a network of post-translational modifications.
CC       PcG proteins maintain the transcriptionally repressive state of genes:
CC       acts as a chromatin compaction factor by recognizing and binding
CC       mono- and dimethylated histone H1b/H1-4 at 'Lys-26' (H1bK26me1 and
CC       H1bK26me2) and histone H4 at 'Lys-20' (H4K20me1 and H4K20me2), leading
CC       to condense chromatin and repress transcription. Recognizes and binds
CC       p53/TP53 monomethylated at 'Lys-382', leading to repress p53/TP53-
CC       target genes. Also recognizes and binds RB1/RB monomethylated at 'Lys-
CC       860'. Participates in the ETV6-mediated repression. Probably plays a
CC       role in cell proliferation. Overexpression induces multinucleated
CC       cells, suggesting that it is required to accomplish normal mitosis.
CC       {ECO:0000269|PubMed:17540172, ECO:0000269|PubMed:18408754,
CC       ECO:0000269|PubMed:20870719, ECO:0000269|PubMed:20870725}.
CC   -!- SUBUNIT: Homodimer. Interacts with RB1/RB (when monomethylated at 'Lys-
CC       860'). Interacts with p53/TP53 (when monomethylated at 'Lys-382').
CC       Interacts with CBX3, ETV6, KMT5A and VCP/p97.
CC       {ECO:0000269|PubMed:12588862, ECO:0000269|PubMed:17540172,
CC       ECO:0000269|PubMed:18026117, ECO:0000269|PubMed:18042461,
CC       ECO:0000269|PubMed:18408754, ECO:0000269|PubMed:20870719,
CC       ECO:0000269|PubMed:20870725, ECO:0000269|PubMed:22120668}.
CC   -!- INTERACTION:
CC       Q9Y468; P10412: H1-4; NbExp=7; IntAct=EBI-1265089, EBI-358163;
CC       Q9Y468; P68431: H3C12; NbExp=2; IntAct=EBI-1265089, EBI-79722;
CC       Q9Y468; P62805: H4C9; NbExp=4; IntAct=EBI-1265089, EBI-302023;
CC       Q9Y468; P49736: MCM2; NbExp=2; IntAct=EBI-1265089, EBI-374819;
CC       Q9Y468; P33992: MCM5; NbExp=2; IntAct=EBI-1265089, EBI-359410;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10445843}.
CC       Note=Excluded from the nucleolus. Does not colocalizes with the PcG
CC       protein BMI1, suggesting that these two proteins do not belong to the
CC       same complex.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=5;
CC         IsoId=Q9Y468-5; Sequence=Displayed;
CC       Name=1; Synonyms=mbt-I;
CC         IsoId=Q9Y468-1; Sequence=VSP_059458;
CC       Name=2; Synonyms=mbt-II;
CC         IsoId=Q9Y468-2; Sequence=VSP_059458, VSP_059459;
CC       Name=3;
CC         IsoId=Q9Y468-3; Sequence=VSP_003901, VSP_059459;
CC       Name=4;
CC         IsoId=Q9Y468-4; Sequence=VSP_059458, VSP_059460;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expression is reduced in
CC       colorectal cancer cell line SW480 and promyelocytic leukemia cell line
CC       HL-60. {ECO:0000269|PubMed:10445843}.
CC   -!- DEVELOPMENTAL STAGE: In interphase cells, it is scattered throughout
CC       the nucleoplasm. In mitotic cells, it strongly associates with
CC       condensed chromosomes from the prophase to telophase.
CC   -!- DOMAIN: The MBT repeat 2 specifically recognizes and binds
CC       monomethylated and dimethylated proteins. In contrast, it does not bind
CC       trimethylated proteins. The MBT repeat 1 does not bind methylated
CC       peptides but inserts a proline ring in a Pro-Ser-Ser/Thr sequence
CC       context. {ECO:0000269|PubMed:18042461}.
CC   -!- PTM: Ubiquitinated in a VCP/p97-dependent way following DNA damage,
CC       leading to its removal from DNA damage sites, promoting accessibility
CC       of H4K20me2 mark for DNA repair protein TP53BP1, which is then
CC       recruited to DNA damage sites. {ECO:0000269|PubMed:22120668}.
CC   -!- MISCELLANEOUS: The L3MBTL1 locus is imprinted. Paternal inherited gene
CC       is expressed, while the maternal inherited gene is silenced.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EAW75958.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAW75961.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAW75962.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U89358; AAC69438.1; -; mRNA.
DR   EMBL; AK299199; BAG61241.1; -; mRNA.
DR   EMBL; AL110279; CAB53714.1; -; mRNA.
DR   EMBL; AL031681; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75958.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471077; EAW75961.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471077; EAW75962.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC039820; AAH39820.1; -; mRNA.
DR   EMBL; AB014581; BAA31656.1; -; mRNA.
DR   CCDS; CCDS13319.1; -. [Q9Y468-1]
DR   CCDS; CCDS46602.2; -. [Q9Y468-5]
DR   PIR; T14794; T14794.
DR   RefSeq; NP_056293.4; NM_015478.6. [Q9Y468-1]
DR   RefSeq; NP_115479.4; NM_032107.4. [Q9Y468-5]
DR   PDB; 1OYX; X-ray; 1.85 A; A/B/C=265-595.
DR   PDB; 1OZ2; X-ray; 1.55 A; A=265-595.
DR   PDB; 1OZ3; X-ray; 1.85 A; A/B/C=265-595.
DR   PDB; 2PQW; X-ray; 2.00 A; A=268-590.
DR   PDB; 2RHI; X-ray; 1.66 A; A=265-594.
DR   PDB; 2RHU; X-ray; 1.90 A; A=274-587.
DR   PDB; 2RHX; X-ray; 2.10 A; A=265-594.
DR   PDB; 2RHY; X-ray; 1.90 A; A=274-587.
DR   PDB; 2RHZ; X-ray; 2.20 A; A=274-587.
DR   PDB; 2RI2; X-ray; 2.20 A; A=274-587.
DR   PDB; 2RI3; X-ray; 2.00 A; A=274-587.
DR   PDB; 2RI5; X-ray; 2.00 A; A=274-587.
DR   PDB; 2RJC; X-ray; 2.00 A; A/B/C=268-598.
DR   PDB; 2RJD; X-ray; 1.65 A; A=268-598.
DR   PDB; 2RJE; X-ray; 1.86 A; A/B/C=268-598.
DR   PDB; 2RJF; X-ray; 2.05 A; A/C/E=268-598.
DR   PDB; 3OQ5; X-ray; 2.50 A; A/B/C=259-598.
DR   PDB; 3P8H; X-ray; 2.55 A; A/B/C=268-590.
DR   PDB; 3UWN; X-ray; 2.15 A; A=268-598.
DR   PDB; 6BYB; X-ray; 1.74 A; A=200-522.
DR   PDBsum; 1OYX; -.
DR   PDBsum; 1OZ2; -.
DR   PDBsum; 1OZ3; -.
DR   PDBsum; 2PQW; -.
DR   PDBsum; 2RHI; -.
DR   PDBsum; 2RHU; -.
DR   PDBsum; 2RHX; -.
DR   PDBsum; 2RHY; -.
DR   PDBsum; 2RHZ; -.
DR   PDBsum; 2RI2; -.
DR   PDBsum; 2RI3; -.
DR   PDBsum; 2RI5; -.
DR   PDBsum; 2RJC; -.
DR   PDBsum; 2RJD; -.
DR   PDBsum; 2RJE; -.
DR   PDBsum; 2RJF; -.
DR   PDBsum; 3OQ5; -.
DR   PDBsum; 3P8H; -.
DR   PDBsum; 3UWN; -.
DR   PDBsum; 6BYB; -.
DR   SMR; Q9Y468; -.
DR   BioGRID; 117486; 93.
DR   ComplexPortal; CPX-469; L3MBTL1 complex.
DR   DIP; DIP-29628N; -.
DR   IntAct; Q9Y468; 100.
DR   MINT; Q9Y468; -.
DR   STRING; 9606.ENSP00000398516; -.
DR   BindingDB; Q9Y468; -.
DR   ChEMBL; CHEMBL1287622; -.
DR   DrugBank; DB03814; 2-(N-morpholino)ethanesulfonic acid.
DR   DrugCentral; Q9Y468; -.
DR   iPTMnet; Q9Y468; -.
DR   PhosphoSitePlus; Q9Y468; -.
DR   BioMuta; L3MBTL1; -.
DR   DMDM; 325511398; -.
DR   jPOST; Q9Y468; -.
DR   MassIVE; Q9Y468; -.
DR   PaxDb; Q9Y468; -.
DR   PeptideAtlas; Q9Y468; -.
DR   PRIDE; Q9Y468; -.
DR   ProteomicsDB; 86115; -. [Q9Y468-4]
DR   ProteomicsDB; 86116; -. [Q9Y468-1]
DR   ProteomicsDB; 86117; -. [Q9Y468-2]
DR   ProteomicsDB; 86118; -. [Q9Y468-3]
DR   ProteomicsDB; 86119; -. [Q9Y468-5]
DR   ABCD; Q9Y468; 3 sequenced antibodies.
DR   Antibodypedia; 27135; 146 antibodies.
DR   DNASU; 26013; -.
DR   Ensembl; ENST00000373135; ENSP00000362227; ENSG00000185513. [Q9Y468-1]
DR   Ensembl; ENST00000422861; ENSP00000410139; ENSG00000185513. [Q9Y468-4]
DR   Ensembl; ENST00000427442; ENSP00000402107; ENSG00000185513. [Q9Y468-5]
DR   GeneID; 26013; -.
DR   KEGG; hsa:26013; -.
DR   UCSC; uc002xkl.4; human. [Q9Y468-5]
DR   CTD; 26013; -.
DR   DisGeNET; 26013; -.
DR   GeneCards; L3MBTL1; -.
DR   HGNC; HGNC:15905; L3MBTL1.
DR   HPA; ENSG00000185513; Low tissue specificity.
DR   MIM; 608802; gene.
DR   neXtProt; NX_Q9Y468; -.
DR   OpenTargets; ENSG00000185513; -.
DR   PharmGKB; PA30260; -.
DR   VEuPathDB; HostDB:ENSG00000185513.14; -.
DR   eggNOG; KOG3766; Eukaryota.
DR   GeneTree; ENSGT00940000159708; -.
DR   HOGENOM; CLU_004064_0_0_1; -.
DR   InParanoid; Q9Y468; -.
DR   OMA; RKNQQRD; -.
DR   OrthoDB; 63195at2759; -.
DR   PhylomeDB; Q9Y468; -.
DR   TreeFam; TF316498; -.
DR   PathwayCommons; Q9Y468; -.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   SIGNOR; Q9Y468; -.
DR   BioGRID-ORCS; 26013; 7 hits in 1020 CRISPR screens.
DR   ChiTaRS; L3MBTL1; human.
DR   EvolutionaryTrace; Q9Y468; -.
DR   GeneWiki; L3MBTL; -.
DR   GenomeRNAi; 26013; -.
DR   Pharos; Q9Y468; Tchem.
DR   PRO; PR:Q9Y468; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9Y468; protein.
DR   Bgee; ENSG00000185513; Expressed in dorsal plus ventral thalamus and 218 other tissues.
DR   ExpressionAtlas; Q9Y468; baseline and differential.
DR   Genevisible; Q9Y468; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0000793; C:condensed chromosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0035064; F:methylated histone binding; IDA:UniProtKB.
DR   GO; GO:0031493; F:nucleosomal histone binding; IDA:UniProtKB.
DR   GO; GO:0031491; F:nucleosome binding; IDA:UniProtKB.
DR   GO; GO:0032093; F:SAM domain binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IDA:UniProtKB.
DR   GO; GO:0030097; P:hemopoiesis; IEP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; NAS:UniProtKB.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   IDEAL; IID00335; -.
DR   InterPro; IPR004092; Mbt.
DR   InterPro; IPR002515; Znf_C2H2C.
DR   InterPro; IPR036060; Znf_C2H2C_sf.
DR   Pfam; PF02820; MBT; 3.
DR   Pfam; PF01530; zf-C2HC; 1.
DR   SMART; SM00561; MBT; 3.
DR   SUPFAM; SSF103637; SSF103637; 1.
DR   PROSITE; PS51079; MBT; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
DR   PROSITE; PS51802; ZF_CCHHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..840
FT                   /note="Lethal(3)malignant brain tumor-like protein 1"
FT                   /id="PRO_0000084452"
FT   REPEAT          274..374
FT                   /note="MBT 1"
FT   REPEAT          382..481
FT                   /note="MBT 2"
FT   REPEAT          490..585
FT                   /note="MBT 3"
FT   DOMAIN          751..824
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   ZN_FING         613..656
FT                   /note="CCHHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   REGION          447..454
FT                   /note="Interaction with monomethylated and dimethylated
FT                   peptides"
FT   SITE            423
FT                   /note="Mediates recognition of monomethylated and
FT                   dimethylated peptides"
FT   SITE            426
FT                   /note="Positioned at the entrance of MBT 2 and is required
FT                   for recognition of monomethylated and dimethylated
FT                   peptides"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..416
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_003901"
FT   VAR_SEQ         1..98
FT                   /note="MHLVAGDSPGSGPHLPATAFIIPASSATLGLPSSALDVSCFPREPIHVGAPE
FT                   QVAGCEPVSATVLPQLSAGPASSSTSTVRLLEWTEAAAPPPGGGLR -> MRRREGHGT
FT                   DSEMGQGPVRESQSSDPPALQ (in isoform 1, isoform 2 and isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:10445843,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9734811"
FT                   /id="VSP_059458"
FT   VAR_SEQ         777..840
FT                   /note="ARIVRVTHVSGKTLVWTVAQLGDLVCSDHLQEGKGILETGVHSLLCSLPTHL
FT                   LAKLSFASDSQY -> VRCKCRVGDRAGVTVLKTAGSRCPPQRHFC (in isoform
FT                   2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10445843,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_059459"
FT   VAR_SEQ         777..840
FT                   /note="ARIVRVTHVSGKTLVWTVAQLGDLVCSDHLQEGKGILETGVHSLLCSLPTHL
FT                   LAKLSFASDSQY -> MIDGEAFLLLTQADIVKIMSVKLGPALKIYNAILMFKNADDTL
FT                   K (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9734811"
FT                   /id="VSP_059460"
FT   VARIANT         117
FT                   /note="S -> T (in dbSNP:rs17857202)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051097"
FT   VARIANT         547
FT                   /note="I -> M (in dbSNP:rs6017104)"
FT                   /id="VAR_051098"
FT   MUTAGEN         316
FT                   /note="D->N: Does not affect binding to monomethylated and
FT                   dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:17540172"
FT   MUTAGEN         340
FT                   /note="F->A: Does not affect binding to monomethylated and
FT                   dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:17540172"
FT   MUTAGEN         423
FT                   /note="D->A: Abolishes binding to monomethylated and
FT                   dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:17540172,
FT                   ECO:0000269|PubMed:18026117, ECO:0000269|PubMed:18042461,
FT                   ECO:0000269|PubMed:20870725"
FT   MUTAGEN         423
FT                   /note="D->N: Strongly impairs binding to monomethylated and
FT                   dimethylated peptides. Abolishes binding to p53/TP53
FT                   monomethylated at 'Lys-382'."
FT                   /evidence="ECO:0000269|PubMed:17540172,
FT                   ECO:0000269|PubMed:18026117, ECO:0000269|PubMed:18042461,
FT                   ECO:0000269|PubMed:20870725"
FT   MUTAGEN         426
FT                   /note="N->A: Abolishes binding to monomethylated and
FT                   dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:18042461,
FT                   ECO:0000269|PubMed:20870725"
FT   MUTAGEN         426
FT                   /note="N->Q: Strongly impairs binding to monomethylated and
FT                   dimethylated peptides. Abolishes binding to p53/TP53
FT                   monomethylated at 'Lys-382'."
FT                   /evidence="ECO:0000269|PubMed:18042461,
FT                   ECO:0000269|PubMed:20870725"
FT   MUTAGEN         431
FT                   /note="C->F,R: Strongly impairs binding to monomethylated
FT                   and dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:18026117"
FT   MUTAGEN         447
FT                   /note="F->A: Abolishes binding to monomethylated and
FT                   dimethylated peptides. Abolishes binding to p53/TP53
FT                   monomethylated at 'Lys-382'."
FT                   /evidence="ECO:0000269|PubMed:17540172,
FT                   ECO:0000269|PubMed:20870725"
FT   MUTAGEN         450
FT                   /note="W->L: Abolishes binding to p53/TP53 monomethylated
FT                   at 'Lys-382'."
FT                   /evidence="ECO:0000269|PubMed:20870725"
FT   MUTAGEN         454
FT                   /note="Y->L: Abolishes binding to p53/TP53 monomethylated
FT                   at 'Lys-382'."
FT                   /evidence="ECO:0000269|PubMed:20870725"
FT   MUTAGEN         527
FT                   /note="D->N: Does not affect binding to monomethylated and
FT                   dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:17540172"
FT   MUTAGEN         551
FT                   /note="F->A: Does not affect binding to monomethylated and
FT                   dimethylated peptides."
FT                   /evidence="ECO:0000269|PubMed:17540172"
FT   CONFLICT        254
FT                   /note="T -> A (in Ref. 2; BAG61241)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="P -> L (in Ref. 1; AAC69438)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388..389
FT                   /note="LR -> MC (in Ref. 1; AAC69438)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        400
FT                   /note="L -> M (in Ref. 1; AAC69438)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        561
FT                   /note="W -> R (in Ref. 2; BAG61241)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        663
FT                   /note="S -> P (in Ref. 1; AAC69438)"
FT                   /evidence="ECO:0000305"
FT   HELIX           276..283
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           290..292
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           295..298
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          311..316
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          319..332
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          335..340
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           345..347
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          349..352
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          356..359
FT                   /evidence="ECO:0007744|PDB:2RJD"
FT   HELIX           363..367
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           379..381
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           384..391
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           398..400
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          418..422
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   TURN            424..427
FT                   /evidence="ECO:0007744|PDB:2RI5"
FT   STRAND          430..439
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          442..447
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           452..454
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          456..458
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           470..474
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           487..489
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           492..499
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           506..508
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          522..526
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          528..530
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          534..542
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          544..551
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           556..558
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   STRAND          560..563
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   HELIX           574..578
FT                   /evidence="ECO:0007744|PDB:1OZ2"
FT   VARIANT         Q9Y468-1:759
FT                   /note="H -> R (in dbSNP:rs6030948)"
FT                   /evidence="ECO:0000305"
FT                   /id="VAR_082883"
SQ   SEQUENCE   840 AA;  92297 MW;  70004D458897CB24 CRC64;
     MHLVAGDSPG SGPHLPATAF IIPASSATLG LPSSALDVSC FPREPIHVGA PEQVAGCEPV
     SATVLPQLSA GPASSSTSTV RLLEWTEAAA PPPGGGLRFR ISEYKPLNMA GVEQPPSPEL
     RQEGVTEYED GGAPAGDGEA GPQQAEDHPQ NPPEDPNQDP PEDDSTCQCQ ACGPHQAAGP
     DLGSSNDGCP QLFQERSVIV ENSSGSTSAS ELLKPMKKRK RREYQSPSEE ESEPEAMEKQ
     EEGKDPEGQP TASTPESEEW SSSQPATGEK KECWSWESYL EEQKAITAPV SLFQDSQAVT
     HNKNGFKLGM KLEGIDPQHP SMYFILTVAE VCGYRLRLHF DGYSECHDFW VNANSPDIHP
     AGWFEKTGHK LQPPKGYKEE EFSWSQYLRS TRAQAAPKHL FVSQSHSPPP LGFQVGMKLE
     AVDRMNPSLV CVASVTDVVD SRFLVHFDNW DDTYDYWCDP SSPYIHPVGW CQKQGKPLTP
     PQDYPDPDNF CWEKYLEETG ASAVPTWAFK VRPPHSFLVN MKLEAVDRRN PALIRVASVE
     DVEDHRIKIH FDGWSHGYDF WIDADHPDIH PAGWCSKTGH PLQPPLGPRE PSSASPGGCP
     PLSYRSLPHT RTSKYSFHHR KCPTPGCDGS GHVTGKFTAH HCLSGCPLAE RNQSRLKAEL
     SDSEASARKK NLSGFSPRKK PRHHGRIGRP PKYRKIPQED FQTLTPDVVH QSLFMSALSA
     HPDRSLSVCW EQHCKLLPGV AGISASTVAK WTIDEVFGFV QTLTGCEDQA RLFKDEARIV
     RVTHVSGKTL VWTVAQLGDL VCSDHLQEGK GILETGVHSL LCSLPTHLLA KLSFASDSQY
//
